Documentdetail
ID kaart

oai:pubmedcentral.nih.gov:7732...

Onderwerp
Articles
Auteur
Seitz, Christian Casalino, Lorenzo Konecny, Robert Huber, Gary Amaro, Rommie E. McCammon, J. Andrew
Langue
en
Editor

The Biophysical Society

Categorie

Biophysical Journal

Jaar

2020

vermelding datum

29-11-2023

Trefwoorden
glycan primary ligand binding site influenza neuraminidase
Metriek

Beschrijving

Influenza neuraminidase is an important drug target.

Glycans are present on neuraminidase and are generally considered to inhibit antibody binding via their glycan shield.

In this work, we studied the effect of glycans on the binding kinetics of antiviral drugs to the influenza neuraminidase.

We created all-atom in silico systems of influenza neuraminidase with experimentally derived glycoprofiles consisting of four systems with different glycan conformations and one system without glycans.

Using Brownian dynamics simulations, we observe a two- to eightfold decrease in the rate of ligand binding to the primary binding site of neuraminidase due to the presence of glycans.

These glycans are capable of covering much of the surface area of neuraminidase, and the ligand binding inhibition is derived from glycans sterically occluding the primary binding site on a neighboring monomer.

Our work also indicates that drugs preferentially bind to the primary binding site (i.e., the active site) over the secondary binding site, and we propose a binding mechanism illustrating this.

These results help illuminate the complex interplay between glycans and ligand binding on the influenza membrane protein neuraminidase.

Seitz, Christian,Casalino, Lorenzo,Konecny, Robert,Huber, Gary,Amaro, Rommie E.,McCammon, J. Andrew, 2020, Multiscale Simulations Examining Glycan Shield Effects on Drug Binding to Influenza Neuraminidase, The Biophysical Society

Delen

Bron

Artikelen aanbevolen door ES/IODE AI

A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
peliosis hepatis metastatic liver tumor oxaliplatin oxaliplatin associated cancer metastatic tumor liver hepatis peliosis